Home | Biogen
Biogen is a leading global biotechnology company that pioneers science and drives innovations for complex and devastating diseases. Biogen is advancing a pipeline of potential therapies across neurology, neuropsychiatry, specialized immunology and rare disease and remains acutely focused on its purpose of serving humanity through science while ...
Company | Biogen
Founded in 1978, Biogen is a leading biotechnology company that pioneers innovative science to deliver new medicines to transform patients’ lives and to create value for shareholders and our communities.
Our Pipeline - Biogen
With a strong focus on difficult-to-treat diseases, our pipeline is focused on research in therapeutic areas where we believe we have the best opportunity to deliver transformational medicines to patients and protect public health.
Careers | Biogen
Everyone at Biogen contributes to our mission to create transformative medicines for people who need them the most. Explore our business areas to discover where you can make an impact on our team.
Multiple Sclerosis - Biogen
As pioneers in neuroscience, Biogen has an innovative therapeutic pipeline that aims to reverse disability, repair damage, and address other remaining unmet needs in MS, with the goal of significantly altering the course of MS and preventing disease development and …
Investor Relations | Biogen
Jan 26, 2025 · Founded in 1978, Biogen is a leading biotechnology company that pioneers innovative science to deliver new medicines to transform patient’s lives and to create value for …
Kidney Disease | Biogen
Through our acquisition of Human Immunology Biosciences (HI-Bio) in July 2024, Biogen officially entered the nephrology space with a portfolio of investigational drugs that target immune-mediated diseases with serious unmet need.
Contact Us | Biogen
SMA Support SMA360°™ 1-844-477-4672 This product support information is applicable to patients who have been prescribed Biogen therapies in the United States only. For product …
Disease Areas - Biogen
Biogen has pioneered the development of multiple sclerosis treatments for more than 25 years. We continue to innovate to advance MS treatment and improve outcomes for patients.
Leadership | Biogen
Meet our executive leadership team